Come up with a name for your new list and we'll add to it:
Carmot Therapeutics raised a round of funding on April 15, 2011. Investors include
National Cancer Institute.
Carmot Therapeutics is applying its technology, Chemotype Evolution, to address unmet chemical needs in drug discovery, focusing on high-profile targets for which drug leads have been difficult to ide…